This is a ready-to-use triage worksheet for the first hours after a warning letter or Form 483. It forces every observation to be read as a symptom of a system, captures scope before it can drift, and starts the containment and disclosure clock. Replace every <<FILL: ...>> placeholder with your own specifics. A worked filled specimen follows. Verify each cited regulation against the current source before you rely on it.
Document control header
| Field | Entry |
|---|---|
| Form title | Warning Letter / 483 Observation Triage Worksheet |
| Document number | <<FILL: FORM-ID, e.g. FRM-REM-001>> |
| Version | <<FILL: version>> |
| Regulatory instrument | <<FILL: 483 / warning letter / non-compliance statement, date and reference>> |
| Prepared by | <<FILL: name, role>> |
| Response due date | <<FILL: 15 business days from receipt>> |
Instructions
- Start this worksheet the day the instrument is received; do not wait for the full remediation plan.
- One row per individual observation, read from the full text, not the summary.
- Complete the systemic-question column for every row; it is the column that determines the true scope.
- Route each row into the remediation program plan and the CAPA process.
- Retain the worksheet for the life of the program and for not less than
<<FILL: retention period>>.
Field definitions
| Field | Format | Required | Who | When |
|---|---|---|---|---|
| Observation number | Text | Yes | Preparer | Day 1 |
| Quoted observation | Text (verbatim) | Yes | Preparer | Day 1 |
| Regulation cited | CFR/Annex reference | Yes | Preparer / RA | Day 1 |
| System(s) involved | Text | Yes | Preparer / SME | Day 1 |
| Product in commerce? | Yes / No / Under review | Yes | QA | Day 1 |
| Immediate containment | Text | Yes | QA / operations | Day 1-2 |
| Systemic question it raises | Text | Yes | QA / SME | Day 1-3 |
| Owner | Name | Yes | Program manager | Day 1-3 |
Triage table
| Obs # | Quoted observation | Regulation cited | System(s) involved | Product in commerce? | Immediate containment | Systemic question it raises | Owner |
|---|---|---|---|---|---|---|---|
<<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
<<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> | <<FILL>> |
Acceptance criteria
- Every observation from the full text has its own row.
- Each row maps to a cited regulation and the systems it touches.
- The product-in-commerce status is decided for each row, and a recall risk assessment is opened where the answer is yes.
- Each row has a systemic question and an owner.
- The response due date is recorded and the internal escalation is done the same day.
References
FDA, Data Integrity and Compliance With Drug CGMP: Questions and Answers (2018). 21 CFR Part 211 (including 211.68, 211.180, 211.194) and 21 CFR Part 11. MHRA GxP Data Integrity Guidance (2018); PIC/S PI 041 (2021) (reference by title; describe, do not paste).
Confirm the current version and clause numbers of each reference before issue.
Revision history
| Version | Date | Author | Summary of change |
|---|---|---|---|
<<FILL: 1.0>> | <<FILL: date>> | <<FILL>> | Initial issue. |
Filled specimen
The following shows the worksheet completed for three illustrative observations. Details are illustrative.
| Obs # | Quoted observation | Regulation cited | System(s) | In commerce? | Immediate containment | Systemic question | Owner |
|---|---|---|---|---|---|---|---|
| 1 | Audit trail disabled on HPLC | 21 CFR 211.68(b) | CDS, 3 HPLCs | Yes, 4 batches | Lock config, witness all changes | Change control, periodic audit trail review | CSV lead |
| 2 | Shared analyst login in LIMS | 21 CFR 211.68(b); Part 11.10(d) | LIMS | Yes | Issue unique IDs, force password reset | Access governance, accountability of records | IT lead |
| 3 | Unofficial “trial” injections deleted | 21 CFR 211.194(a) | CDS | Under review | Forensic hold on CDS database | Testing into compliance, second-person review | QC manager |
The right-hand systemic-question column is the one that matters most: it turns “one HPLC had its audit trail off” into “we have a change control, configuration management, and audit-trail-review problem,” which is how the reviewer will read it and how the remediation must be scoped.
Common inspection findings this form prevents
- Remediation scoped to the exact items named, missing the systems behind them.
- Product-in-commerce risk not assessed at the start, so a recall decision is made late.
- Observations read from the summary rather than the full text, so detail is lost.
- No owner assigned, so observations fall between functions.
- The response clock started late because internal escalation was delayed.
How to adapt this form
- Start it the day the instrument arrives; one row per observation from the full text.
- Map every row to its cited regulation and systems, and decide the in-commerce status.
- Fill the systemic-question column for every row; it drives the true scope.
- Assign an owner per row and feed each into the program plan and CAPA.
- Record the response due date and confirm same-day internal escalation.